ProQuest Associates IV’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
$9.56M Hold
38,228
18.05% 2
2018
Q2
$17.1M Hold
38,228
26.27% 2
2018
Q1
$15.1M Hold
38,228
17.33% 2
2017
Q4
$15.7M Hold
38,228
20.86% 2
2017
Q3
$16.5M Hold
38,228
16.55% 3
2017
Q2
$13.4M Buy
+38,228
New +$13.4M 17.07% 4